Comparison of residence time estimation methods for radioimmunotherapy dosimetry and treatment planning-Monte Carlo simulation studies

IEEE Transactions on Medical Imaging

Volumn 27, Issue 4, 2008, Pages 521-530

  He, Bin ^a,b   Wahl, Richard L ^a,b   Du, Yong ^b   Sgouros, George ^b   Jacene, Heather ^b   Flinn, Ian ^c   Frey, Eric C ^a,b  

^a IEEE

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Absolute quantitation; Quantitative SPECT; Radioimmunotherapy; Residence time

Indexed keywords

COMPUTERIZED TOMOGRAPHY; IMAGE RECONSTRUCTION; IMMUNOLOGY; RADIOLOGY; TUMORS;

ABSOLUTE QUANTITATION; RADIOIMMUNOTHERAPY (RIT); RESIDENCE TIME;

DOSIMETRY;

ARTICLE; BIOLOGICAL MODEL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; EVALUATION; HUMAN; METHODOLOGY; MONTE CARLO METHOD; RADIATION DOSE; RADIOIMMUNOTHERAPY; RADIOMETRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

COMPUTER SIMULATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MODELS, BIOLOGICAL; MONTE CARLO METHOD; RADIOIMMUNOTHERAPY; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 41649099345     PISSN: 02780062     EISSN: None     Source Type: Journal    
DOI: 10.1109/TMI.2007.908131     Document Type: Article

References (40)

1. K. Ogawa, Y. Harata, and I. Takashi et al., "A practical method for position-dependent compton-scatter correction in SPECT," IEEE Trans. Med. Imag., vol. 10, no. 3, pp. 408-412, Sep. 1991.
2. R. J. Jaszczak, K. L. Greer, C. E. Floyd, C. C. Harris, and R. E. Coleman, "Improved SPECT quantification using compensation for scattered photons," J. Nucl. Med., vol. 29, no. 8, pp. 893-900, 1984.
3. S. R. Thomasa, H. R. Maxon, J. G. Kernakes, and E. L. Saenger, "Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer," Radiology, vol. 122, pp. 731-737, 1972.
4. R. Loevinger and M. Berman, A Revised Schema for Calculating the Absorbed Dose From Biologically Distributed Radionuclides. New York: Society of Nuclear Medicine, 1976.
5. R. Loevinger, T. Budinger, and E. Watson, MIRD Primer For Absorbed Dose Calculations. New York: Society of Nuclear Medicine, 1988.
6. M. G. Stabin, R. B. Sparks, and E. Crowe, "OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine," J. Nucl. Med., vol. 46, pp. 1023-1027, 2005.
7. S. R. Thomas, H. R. Maxon, and J. G. Kereiakes, "In vivo quantitation of lesion radioactivity using external counting methods," Med. Phys., vol. 3, no. 4, pp. 253-255, 1976.
8. N. D. Hammond, P. J. Moldofsky, M. R. Beardsley, and C. B. Mulhern, Jr., "External imaging techniques for quantitation of distribution of 1-131 f(ab′)2 fragments of monoclonal antibody in humans," Med. Phys., vol. 11, no. 6, pp. 778-783, 1984.
9. R. K. Wu and J. A. Siegel, "Absolute quantitation of radioactivity using the buildup factor," Med. Phys., vol. 11, pp. 189-192, 1984.
10. P. K. Leichner, K. F. Koral, and R. J. Jaszczak et al., "An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy (RTI)," Med. Phys., vol. 20, pp. 569-577, 1993.
11. K. F. Koral, K. R. Zasadny, and M. L. Kessler et al., "CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients," J. Nuc. Med., vol. 35, pp. 1714-1720, 1994.
12. K. F. Koral, Y. K. Dewaraja, and J. Li et al., "Initial results for hybrid spect-conjugate-view tumor dosimetry in i-anti-b1-antibody therapy of previously-untreated lymphoma patients," J. Nucl. Med., vol. 41, pp. 1579-1586, 2000.
13. K. F. Koral, Y. K. Dewaraja, and J. Li et al., "Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131i-tositumomab therapy of previously untreated lymphoma patients," J. Nucl Med.,vol. 44, pp. 457-464, 2003.
14. K. F. Koral and Y. K. Dewaraja, "I-131 SPECT activity recovery coefficients with implicit or triple-energy window scatter correction," Nucl. Instrum. Methods Phys. Res. Sect A, vol. 422, no. 1-3, pp. 688-692, 1999.
15. Y. K. Dewaraja, M. Ljungberg, and K. F. Koral, "Accuracy of 1-131 quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study," J. Nucl Med., vol. 41, no. 10, pp. 1760-1767, 2000.
16. Y. K. Dewaraja, M. Ljungberg, and K. F. Koral, "Characterization of scatter and penetration using Monte Carlo simulation in 13.1I imaging," J. Nucl. Med., vol. 41, no. 1, pp. 123-130, 2000.
17. Y. K. Dewaraja, M. Ljungberg, and K. F. Koral, "Monte carlo evaluation of object shape effects in iodine-13.1 SPET tumor activity quantification," Eur. J. Nucl Med., vol. 28, no. 7, pp. 900-906, 2001.
18. H. R. Tang, J. K. Brown, A. J. Da Silva, K. K. Matthay, D. C. Price, I. P. Huberty, R. A. Hawkins, and B. H. Hasegawa, "Implementation of a combined X-ray ct-scintillation camera imaging system for localizing and measuring radionuclide uptake: Experiments in phantoms and patients," IEEE Trans. Nucl Set, vol. 46, no. 3, pp. 551-557, Jun. 1999.
19. H. R. Tang, A. J. Da Silva, K. K. Matthay, D. C. Price, J. P. Huberty, R. A. Hawkins, and B. H. Hasegawa, "Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG," J. Nucl Med., vol. 42, pp. 237-247, 2001.
20. H. R. Tang, J. K. Brown, and B. H. Hasegawa, "Use of X-ray ct-defined regions of interest for the determination of SPECT recovery coefficients," IEEE Trans. Nucl. Sci., vol. 44, no. 4, pp. 1594-1599, Aug. 1997.
21. K. K. Matthay, C. Panina, and I. P. Huberty et al., "Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG," J. Nucl. Med., vol. 42, no. 11, pp. 1713-1721, 2001.
22. K. Sjogreen, M. Ljungberg, and S. E. Strand, "An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 1-131," J. Nucl Med., vol. 43, no. 7, pp. 972-982, 2002.
23. M. Ljungberg, K. Sjogreen, X. W. Liu, E. C. Frey, Y. K. Dewaraja, and S. E. Strand, "A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: Evaluation for 1-131 using Monte Carlo simulation," J. Nucl. Med., vol. 43, no. 8, pp. 1101-1109, 2002.
24. M. Ljungberg, E. C. Frey, K. Sjogreena, X. W. Liu, Y. K. Dewaraja, and S. E. Strand, "3-D absorbed dose calculations based on SPECT: Evaluation for 111-in/90-y therapy using Monte Carlo simulations," Cancer Biotherapy Radiopharmaceuticals, vol. 18, no. 1, pp. 99-107, 2003.
25. W. P. Segars, "Development of a new dynamic nurbs-based cardiactorso (NCAT) phantom," Ph.D. dissertation, Univ. North Carolina, Chapel Hill, 2001.
26. Y. Du, E. C. Frey, W. T. Wang, and B. M. W. Tsui, "Combination of MCNP and simset for Monte Carlo simulation of SPECT with medium-and high-energy photons," IEEE Trans. Nucl. Sci., vol. 49, no. 3, pp. 668-674, Jun. 2002.
27. X. Song, W. P. Segars, Y. Du, B. M. W. Tsui, and E. C. Frey, "Fast modeling of the collimator-detector response in monte carlo simulation of SPECT imaging using the angular response function," Phys. Med. Biol., vol. 50, pp. 1791-1804, 2005.
28. B. M. W. Tsui, E. C. Frey, X. Zhao, D. S. Lalush, R. E. Johnston, and W. H. McCartney, "The importance and implementation of accurate 3-D compensation methods for quantitative SPECT," Phys. Med Biol., vol. 39, no. 3, p. 509, 1994.
29. E. C. Frey and B. M. W. Tsui, "A new method for modeling the spatially variant object dependent scatter response function in SPECT," in 1996 IEEE Nucl. Sci Symp. Conf. Rec., Anaheim, CA, Nov. 1996, vol. 2, pp. 1082-1086.
30. D. J. Kadrmas, E. C. Frey, S. S. Karimi, and B. M. W. Tsui, "Fast implementations of reconstruction-based scatter compensation in fully 3-D SPECT image reconstruction," Phys. Med. Biol., vol. 43, no. 4, pp. 857-874, 1998.
31. W. T. Wang, E. C. Frey, B. M. W. Tusi, C. Tocharoenchai, and W. H. Baird, "Parameterization of pb X-ray contamination in simultaneous tl-201 and tc-99m. dual-isotope imaging," IEEE Trans. Nucl Sci., vol. 49, no. 3, pp. 680-692, Jun. 2002.
32. Y. Du, B. M. W. Tsui, and E. C. Frey, "Partial volume effect compensation for quantitative brain SPECT imaging," IEEE Trans. Med. Imag., vol. 24, no. 8, pp. 969-976, Aug. 2005.
33. B. M. W. Tsui, X. Zhao, W. P. Segars, S. Sayeram, and E. C. Frey, "Quantitative in-111 PROSTASCINT SPECT imaging and fusion with anatomical CT images," J. Nucl. Med., vol. 43, no. 5, pp. 54-, 2002.
34. B. He, E. C. Frey, Y. Du, X. Song, and W. P. Segars, "A monte carlo and physical phantom evaluation of quantitative SPECT for in-111," Phys. Med. Biol., vol. 50, pp. 4169-4185, 2005.
35. P. C. van Reenen, M. G. Lotter, and A. D. Heyns et al., "Quantification of the distribution of 111in-labelled platelets in organs," Eur. J. Nucl. Med., vol. 7, pp. 80-84, 1982.
36. J. A. Siegel, S. R. Thomasa, and J. B. Stubbs et al., "MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates," J. Nucl. Med., vol. 40, pp. 37S-61S, 1999.
37. H. M. Hudson and R. S. Larkin, "Accelerated image reconstruction using ordered subsets of projection data," IEEE Trans. Med Imag., vol. 13, no. 4, pp. 601-609, Dec. 1994.
38. Y. Seo, K. H. Wong, and B. H. Hasegawa, "Calculation and validation of the use of effective attenuation coefficient for attenuation correction in in-111 SPECT,"Med. Phys., vol. 32, no. 12, pp. 3625-3628, 2005.
39. B. He, "Development and validation of in vivo quantitative imaging methods for targeted radiotherapy treatment planning," Ph.D. dissertation, Johns Hopkins Univ., Baltimore, MD, 2006.
40. E. C. Frey, B. He, G. Sgorous, I. Flinn, and R. L. Wahl, "Estimation of post-therapy marrow dose rate in myeloablative Y-90 ibritumomab tiuxetan therapy," J. Nucl. Med., vol. 47, no. 5, p. 156, 2006.